Press Release March 29, 2010

Goodwin Procter Counsels Anthera Pharmaceuticals on IPO

BOSTON, March 29, 2010 – Goodwin Procter recently advised Anthera Pharmaceuticals as the company completed its $42 million initial public offering.  Deutsche Bank Securities was the sole book-running manager of the offering, Piper Jaffray & Co. was co-lead manager and Cowen and Company, LLC and Merriman Curhan Ford & Co acted as co-managers.

Concurrently with the completion of the offering, Anthera sold approximately $17 million of common stock to existing investors in a private placement and issued $3.5 million to Eli Lilly and Shionogi & Co. in satisfaction of future milestone payment obligations. 

Anthera is a San Francisco Bay Area-based biopharmaceutical company focused on developing and commercializing products to treat serious diseases associated with inflammation, including cardiovascular and autoimmune diseases. 

The Goodwin Procter deal team consisted of Bradley A. Bugdanowitz, Mitzi Chang, Seth D. Greenstein and J. Lauren Walz.

About Goodwin Procter
Goodwin Procter LLP is one of the nation’s leading law firms with offices in Boston, Hong Kong, London, Los Angeles, New York, San Diego, San Francisco, Silicon Valley, and Washington, D.C. The firm’s core areas of practice are corporate, litigation and real estate, with specialized areas of focus that include financial services, private equity, technology, REITs and real estate capital markets, intellectual property, products liability and mass torts. Information may be found at www.goodwinprocter.com.